Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
PCN82 Cost-Effectiveness Of Eml4-Alk Fusion...
Conference

PCN82 Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario

Authors

Djalalov S; Hoch JS; Beca J; Krahn M; Tsao MS; Cutz JC; Leighl N

Volume

16

Publisher

Elsevier

Publication Date

May 2013

DOI

10.1016/j.jval.2013.03.696

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015